Search results for " COVID."

showing 10 items of 510 documents

Appendectomy during the COVID-19 pandemic in Italy: a multicenter ambispective cohort study by the Italian Society of Endoscopic Surgery and new tech…

2021

AbstractMajor surgical societies advised using non-operative management of appendicitis and suggested against laparoscopy during the COVID-19 pandemic. The hypothesis is that a significant reduction in the number of emergent appendectomies was observed during the pandemic, restricted to complex cases. The study aimed to analyse emergent surgical appendectomies during pandemic on a national basis and compare it to the same period of the previous year. This is a multicentre, retrospective, observational study investigating the outcomes of patients undergoing emergent appendectomy in March–April 2019 vs March–April 2020. The primary outcome was the number of appendectomies performed, classifie…

medicine.medical_specialtyCOVID-19 PandemicCoronavirus disease 2019 (COVID-19)Endoscopic surgeryNOAppendectomy; Appendicitis; COVID-19 Pandemic; Machine learningCohort Studies03 medical and health sciences0302 clinical medicinePostoperative ComplicationsRetrospective StudiePandemicMachine learningmedicineHumansAppendectomyAppendicitiLaparoscopyPandemicsRetrospective Studiesmedicine.diagnostic_testPandemicbusiness.industryCOVID-19 Pandemic Appendicitis Appendicectomy Machine learningSARS-CoV-2COVID-19Length of Staymedicine.diseaseAppendicitisAppendicitisSettore MED/18SurgeryItaly030220 oncology & carcinogenesisAppendectomy; appendicitis; COVID-19 pandemic; machine learning; appendectomy; cohort studies; humans; Italy; length of stay; pandemics; postoperative complications; retrospective studies; SARS-CoV-2; appendicitis; COVID-19; laparoscopy030211 gastroenterology & hepatologySurgeryObservational studyOriginal ArticleLaparoscopyPostoperative ComplicationAppendicectomyCohort StudiebusinessComplicationCohort studyHuman
researchProduct

Management of patients with Intestinal Bowel Disease and COVID-19: A review of current evidence and future perspectives

2022

La pandemia por COVID-19 ha supuesto un reto para los países y sus profesionales sanitarios. La entrada viral en el hospedador a través del receptor ACE-2 y una activación excesiva del sistema inmunológico son claves para comprender tanto la incidencia como la gravedad de la enfermedad. La enfermedad inflamatoria intestinal (EII) representa una condición especial asociada con una respuesta descontrolada del sistema inmunológico a agentes externos. Los tratamientos para la EII se han asociado con un mayor riesgo de infecciones bacterianas y virales. Esto ha planteado la cuestión de una posible mayor incidencia y gravedad de la infección por COVID-19 en pacientes con EII. A lo largo de este a…

medicine.medical_specialtyCOVID-19 VaccinesIBD-treatmentCOVID-19 VaccinePopulationDiseaseIncidencia por COVID-19COVID-19 graveInflammatory bowel diseaseSulfasalazineInternal medicinetratamiento de la EIIPandemicmedicineHumansEnfermedad Inflamatoria Intestina (EII)Inflammatory Bowel Disease (IBD)educationSevere COVID-19Pandemicseducation.field_of_studyTofacitinibHepatologybusiness.industryVacuna COVID-19Incidence (epidemiology)GastroenterologyRevisadoCOVID-19General Medicinemedicine.diseaseInflammatory Bowel DiseasesVaccinationCOVID-19 incidenceTumor Necrosis Factor Inhibitorsbusinessmedicine.drugGastroenterología y Hepatología (English Edition)
researchProduct

Italian association for the study of the liver position statement on SARS-CoV2 vaccination.

2021

The vaccination campaign against Sars-CoV-2 commenced in Italy at the end of December 2020. The first ones to receive the immunization against the virus were the health workers and the residents of nursing homes, following which the vaccine would be available for the entire population, beginning with the most vulnerable individuals. SARS-CoV2 vaccines have been demonstrated to be safe for the general population, although no data for patients with liver diseases or those having undergone liver transplantation are available so far. The present position statement AISF is an attempt to suggest, based on the published data on the impact of Sars-Cov-2 infection in patients with chronic liver dise…

medicine.medical_specialtyCOVID-19 VaccinesSars-CoV-2medicine.medical_treatmentPopulationLiver transplantationChronic liver diseaseRisk AssessmentPatient safetyEpidemiologyMedicineChronic liver disease Sars-CoV-2 Vaccination Humans Immunosuppressive Agents Italy Liver Transplantation Patient Safety Patient Selection Risk Adjustment Risk Assessment SARS-CoV-2 Transplant Recipients Treatment Outcome COVID-19 COVID-19 Vaccines Immunization Programs Liver DiseasesHumanseducationeducation.field_of_studyHepatologybusiness.industryImmunization ProgramsLiver DiseasesPatient SelectionChronic liver disease; Sars-CoV-2; VaccinationVaccinationChronic liver diseaseGastroenterologyCOVID-19medicine.diseaseTransplant RecipientsLiver TransplantationVaccinationTreatment OutcomeImmunizationItalyFamily medicineChronic liver disease; Sars-CoV-2; Vaccination; Humans; Immunosuppressive Agents; Italy; Liver Transplantation; Patient Safety; Patient Selection; Risk Adjustment; Risk Assessment; SARS-CoV-2; Transplant Recipients; Treatment Outcome; COVID-19; COVID-19 Vaccines; Immunization Programs; Liver DiseasesRisk AdjustmentPatient SafetyPosition PaperbusinessRisk assessmentImmunosuppressive AgentsDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic

2021

ObjectiveTo evaluate the efficacy of clinical triage of oncological patients for safe continuation of cancer therapy implemented during the first SARS-CoV-2 outbreak.MethodsBetween 25 February and 21 April 2020, patients attending the Medical Oncology Unit, Spedali Civili Hospital, Brescia (Italy) for cancer therapy underwent triage to identify those with no signs and symptoms suspicious for SARS-CoV-2 infection in which antineoplastic treatment could be continued as scheduled. Triage questions investigated common symptoms (e.g., fever, cough, dyspnea, anosmia, dysgeusia, headache, nasal congestion, conjunctival congestion, sore throat, diarrhea, nausea and vomiting); body temperature and p…

medicine.medical_specialtyCancer Researchbusiness.industryNauseapandemicAnosmiaCancerNeoplasms. Tumors. Oncology. Including cancer and carcinogensCOVID-19SARS-COV-2Nasal congestionmedicine.diseaseTriageanticancer therapy; COVID-19; oncology; pandemic; SARS-COV-2DysgeusiaOncologyInternal medicinemedicineSore throatVomitinganticancer therapymedicine.symptombusinessRC254-282Original ResearchFrontiers in Oncology
researchProduct

SARS-CoV-2 and the Risk Assessment Document in Italian Work: Specific or Generic Risk Even If Aggravated?

2021

In December 2019, several cases of atypical pneumonia were detected in Wuhan city, Hubei province, inland China. The initial outbreak was of considerable size first in China subsequently spread to the rest of the world. Immediately after the epidemic (which according to the World Health Organization had risen to pandemic status), the problem of whether or not to update the occupational risk assessment arose, also considering how the biological risk from SARS CoV-2 should be understood: specific or generic. To this end, we conducted a literature review to identify national health legislation and policies, examining how Italy has addressed the COVID-19 emergency in occupational health plannin…

medicine.medical_specialtyChinaoccupational medicineHealth Toxicology and Mutagenesislcsh:MedicineLegislationReviewSettore MED/42 - Igiene Generale E ApplicataRisk AssessmentOccupational safety and healthOccupational medicine03 medical and health sciences0302 clinical medicineCOVID-19 Decree 81/2008 Law Occupational medicine Prevention and protection measures Risk assessment document Work China Humans Italy Risk Assessment COVID-19 SARS-CoV-2workEnvironmental healthPandemicmedicineHumansprevention and protection measures030212 general & internal medicinelawChina0303 health sciences030306 microbiologySARS-CoV-2lcsh:RPublic Health Environmental and Occupational HealthCOVID-19medicine.diseasedecree 81/2008Work (electrical)Italyrisk assessment documentAtypical pneumoniaBusinessRisk assessment
researchProduct

The Role of Endothelium in COVID-19

2021

The 2019 novel coronavirus, known as severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) or coronavirus disease 2019 (COVID-19), is causing a global pandemic. The virus primarily affects the upper and lower respiratory tracts and raises the risk of a variety of non-pulmonary consequences, the most severe and possibly fatal of which are cardiovascular problems. Data show that almost one-third of the patients with a moderate or severe form of COVID-19 had preexisting cardiovascular comorbidities such as diabetes mellitus, obesity, hypertension, heart failure, or coronary artery disease. SARS-CoV2 causes hyper inflammation, hypoxia, apoptosis, and a renin–angiotensin system imbalance …

medicine.medical_specialtyComplications Endothelium Pathogenesis COVID-19 Cytokine Release Syndrome Endothelial Cells Heart Failure Humans Renal Insufficiency Renin-Angiotensin System SARS-CoV-2 ThrombosisEndotheliumendotheliumcomplicationsQH301-705.5InflammationReviewCatalysisRenin-Angiotensin SystemInorganic ChemistryCoronary artery diseasePathogenesisInternal medicineDiabetes mellitusHumansMedicineRenal InsufficiencyBiology (General)Physical and Theoretical ChemistryEndothelial dysfunctionQD1-999Molecular BiologySpectroscopyHeart Failurebusiness.industrySARS-CoV-2pathogenesisOrganic ChemistryEndothelial CellsCOVID-19ThrombosisGeneral MedicineHypoxia (medical)medicine.diseaseComputer Science ApplicationsChemistrymedicine.anatomical_structureHeart failureCardiologymedicine.symptomCytokine Release SyndromebusinessInternational Journal of Molecular Sciences
researchProduct

Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management

2020

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Endocrinology Diabetes and MetabolismPneumonia ViralType 2 diabetesDiabetes ComplicationsDisease susceptibilityInsulin resistanceDiabetes mellitusPandemicmedicineInternal MedicineDiabetes MellitusHumansEndothelial dysfunctionIntensive care medicinePandemicsbusiness.industryCOVID-19medicine.diseaseObesityCommentarycardiovascular disease endothelial dysfunction insulin resistance obesity type 2 diabetes COVID-19 Coronavirus Infections Diabetes Complications Diabetes Mellitus Disease Susceptibility Humans Pandemics Pneumonia ViralDisease SusceptibilitybusinessCoronavirus Infections
researchProduct

Contratto ed emergenza sanitaria in Italia

2021

 Questo articolo si propone di analizzare il disastro globale causato dall'epidemia di COVID-19 che ha turbato l'esistenza di quasi tutta l'umanità. Esaminare le significative limitazioni alle libertà individuali e collettive per proteggere la salute pubblica e, in secondo luogo, mitigare il più possibile l'impatto della pandemia sulle attività economiche. L'attenzione dell'articolo si concentrerà esclusivamente sulle norme che impattano sulla disciplina generale delle obbligazioni e dei contratti, tralasciando le importantissime disposizioni in materia di rapporti di lavoro, contratti di mutuo, contratti bancari e assicurativi, ecc. Verificherà fino a che punto la situazione sociale, sanit…

medicine.medical_specialtyEconomic policyPublic healthGeneral MedicineGeneral ChemistryLabor relationsState of emergencyLoanInsurance policyHumanityPandemicmedicineContract Obligations COVID-19 pandemic Impossibility of Performance RenegotiationSettore IUS/01 - Diritto PrivatoBusinessState of exception
researchProduct

Implementation of Sample Pooling Procedure Using a Rapid SARS-CoV-2 Diagnostic Real-Time PCR Test Performed Prior to Hospital Admission of People wit…

2021

Reliability, accuracy, and timeliness of diagnostic testing for SARS-CoV-2 infection have allowed adequate public health management of the disease, thus notably helping the timely mapping of viral spread within the community. Furthermore, the most vulnerable populations, such as people with intellectual disability and dementia, represent a high-risk group across multiple dimensions, including a higher prevalence of pre-existing conditions, lower health maintenance, and a propensity for rapid community spread. This led to an urgent need for reliable in-house rapid testing to be performed prior to hospital admission. In the present study, we describe a pooling procedure in which oropharyngeal…

medicine.medical_specialtyHealth Toxicology and MutagenesisPoolingRT-PCRsample poolingSample (statistics)DiseaseReal-Time Polymerase Chain ReactionSensitivity and SpecificityIntellectual DisabilityIntellectual disabilitymedicineHumansDementiaHospital admission RT-PCR Sample pooling SARS-CoV-2 Sensitivity Hospitals Humans Real-Time Polymerase Chain Reaction Reproducibility of Results SARS-CoV-2 Sensitivity and Specificity COVID-19 Intellectual DisabilitySARS-CoV-2business.industryBrief ReportPublic healthRPublic Health Environmental and Occupational HealthCOVID-19Reproducibility of Resultssensitivitymedicine.diseaseHospitalsTest (assessment)hospital admissionEmergency medicineMedicineSample collectionbusinessInternational Journal of Environmental Research and Public Health
researchProduct

Covid-19 and Congenital Heart Disease: results from a nationwide survey

2020

Background. The pandemic of Novel Coronavirus Disease 2019 (COVID-19) is challenging, given the large number of hospitalized patients. Cardiovascular co-morbidities are linked to a higher mortality risk. Thus, patients with Congenital Heart Disease (CHD) might represent a high-risk population. Nevertheless, no data about them are available, yet. Hence, we conducted a nationwide survey to assess clinical characteristics and outcomes in patients with congenital heart disease affected by COVID-19. Methods and Results. This is a multi-centre, observational, nationwide survey, involving high-volume Italian CHD centres. COVID-19 diagnosis was defined as either &ldquo

medicine.medical_specialtyHeart diseasePopulationcardiovascular complicationslcsh:Medicine030204 cardiovascular system & hematologyChest painArticle03 medical and health sciences0302 clinical medicineDiabetes mellitusInternal medicinecongenital heart disease COVID-19 cardiovascular complicationsmedicinePalpitations030212 general & internal medicineeducationStrokecardiovascular complicationeducation.field_of_studybusiness.industrylcsh:Rcongenital heart disease; COVID-19; cardiovascular complicationsCOVID-19General Medicinemedicine.diseasecongenital heart diseaseHeart failureCohortmedicine.symptombusiness
researchProduct